Literature DB >> 3652046

Inhibition of lymphoma invasion and liver metastasis formation by pertussis toxin.

E Roos1, I V Van de Pavert.   

Abstract

We have examined whether pertussis toxin, an agent known to inhibit entry of normal lymphocytes into tissues, affects invasion and metastasis formation by malignant lymphoma and T-cell hybridoma cells. The toxin reduced invasion in vitro in hepatocyte cultures to 20% of control values. Inhibition was maximal after pretreatment for 2 h with approximately 100 ng/ml. The effect of pretreatment with 1 to 5 micrograms toxin/ml for 4 h persisted for at least 5 days, despite a more than 100-fold increase in cell number. The proliferation rate was not affected. Liver metastasis formation after tail vein injection of TAM2D2 T-cell hybridoma cells in syngeneic AKR mice, measured as liver weight, was reduced to 10 to 25% of controls after pretreatment of the cells for 4 h with 1 microgram pertussis toxin/ml. Metastasis to kidneys, ovaries, and lymph nodes was not, or less evidently, affected. With MB6A lymphosarcoma cells no effect was seen after treatment with 1 microgram/ml, but a significant reduction of the liver tumor burden to approximately 50% of controls was achieved by treatment with at least 5 micrograms toxin/ml. Spleen metastasis by MB6A cells was not affected. These results provide evidence for a similarity in invasion mechanisms of normal and malignant lymphoid cells, and they suggest that invasiveness is an important factor in the formation of lymphoma metastases, particularly in the liver.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3652046

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Interaction of B-cell hybridomas with fibroblast or hepatocyte monolayers in vitro and their metastatic behaviour in vivo.

Authors:  S Verhaegen; H Verschueren; J Brissinck; D Van Hecke; D Dekegel; P De Baetselier
Journal:  Clin Exp Metastasis       Date:  1991 Mar-Apr       Impact factor: 5.150

2.  Tumour necrosis factor-alpha stimulates invasiveness of T-cell hybridomas and cytotoxic T-cell clones by a pertussis toxin-insensitive mechanism.

Authors:  G La Rivière; J W Klein Gebbinck; C A Schipper; E Roos
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

3.  Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells.

Authors:  S Aznavoorian; M L Stracke; H Krutzsch; E Schiffmann; L A Liotta
Journal:  J Cell Biol       Date:  1990-04       Impact factor: 10.539

4.  Dual effects of pertussis toxin on in vitro invasive behavior of metastatic lymphoma variants.

Authors:  H Verschueren; D Van Hecke; E Hannecart-Pokorni; D Dekegel; P De Baetselier
Journal:  Clin Exp Metastasis       Date:  1989 Sep-Oct       Impact factor: 5.150

Review 5.  Adhesion molecules in lymphoma metastasis.

Authors:  E Roos
Journal:  Cancer Metastasis Rev       Date:  1991-05       Impact factor: 9.264

Review 6.  The invasive phenotypes.

Authors:  M M Mareel; F M Van Roy; P De Baetselier
Journal:  Cancer Metastasis Rev       Date:  1990-07       Impact factor: 9.264

Review 7.  Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1988-06       Impact factor: 9.264

Review 8.  Tumor cell adhesion to the extracellular matrix and signal transduction mechanisms implicated in tumor cell motility, invasion and metastasis.

Authors:  B R Lester; J B McCarthy
Journal:  Cancer Metastasis Rev       Date:  1992-03       Impact factor: 9.264

9.  ZAP-70 tyrosine kinase is required for LFA-1-dependent T cell migration.

Authors:  R D Soede; Y M Wijnands; I Van Kouteren-Cobzaru; E Roos
Journal:  J Cell Biol       Date:  1998-09-07       Impact factor: 10.539

10.  Intracellular Signal-transducing elements involved in transendothelial migration of lymphoma cells.

Authors:  S Tsuzuki; N Toyama-Sorimachi; F Kitamura; H Tsuboi; J Ando; T Sakurai; N Morii; S Narumiya; M Miyasaka
Journal:  Jpn J Cancer Res       Date:  1998-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.